chr12-9756418-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001781.2(CD69):āc.66T>Gā(p.Asn22Lys) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,613,212 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001781.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD69 | NM_001781.2 | c.66T>G | p.Asn22Lys | missense_variant, splice_region_variant | 2/5 | ENST00000228434.7 | NP_001772.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD69 | ENST00000228434.7 | c.66T>G | p.Asn22Lys | missense_variant, splice_region_variant | 2/5 | 1 | NM_001781.2 | ENSP00000228434.3 | ||
CD69 | ENST00000536709.1 | c.66T>G | p.Asn22Lys | missense_variant, splice_region_variant | 2/4 | 2 | ENSP00000442597.1 | |||
CD69 | ENST00000416624.6 | n.147T>G | splice_region_variant, non_coding_transcript_exon_variant | 2/3 | 2 | |||||
CD69 | ENST00000543147.1 | n.147T>G | splice_region_variant, non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152234Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 250694Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135522
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1460978Hom.: 0 Cov.: 30 AF XY: 0.00000963 AC XY: 7AN XY: 726796
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152234Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74392
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2021 | The c.66T>G (p.N22K) alteration is located in exon 2 (coding exon 2) of the CD69 gene. This alteration results from a T to G substitution at nucleotide position 66, causing the asparagine (N) at amino acid position 22 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at